Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

A study co-authored by eight BYU students and three BYU faculty finds that exposure to the exhaust gas produced by diesel ...

It had started in 2022, just months after the drug was introduced with the brand Mounjaro for diabetes. Tirzepatide was approved as Zepbound in late 2023 as a weight-loss treatment.

More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...

A quarter of a million people are set to receive the “King Kong” of weight loss jabs ... support many more people to lose weight and reduce their risk of diabetes, heart attack and stroke".

Dr. Christopher McGowan, MD, an obesity medicine specialist at True You Weight Loss, says the decision to drink on Ozempic is ...

Brands like Kourtney Kardashian’s Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

The U.S. Food and Drug Administration says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved. Tirzepatide injection has ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...